{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:07:07Z","timestamp":1782475627829,"version":"3.54.5"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We determined the in vitro susceptibilities of 314 strains of\n            <jats:italic>Candida<\/jats:italic>\n            spp., representing 13 species rarely isolated from blood, to posaconazole and voriconazole as well as four licensed systemic antifungal agents (amphotericin B, flucytosine, fluconazole, and itraconazole). The organisms included 153 isolates of\n            <jats:italic>C. krusei<\/jats:italic>\n            , 67 isolates of\n            <jats:italic>C. lusitaniae<\/jats:italic>\n            , 48 isolates of\n            <jats:italic>C. guilliermondii<\/jats:italic>\n            , 10 isolates of\n            <jats:italic>C. famata<\/jats:italic>\n            , 10 isolates of\n            <jats:italic>C. kefyr<\/jats:italic>\n            , 6 isolates of\n            <jats:italic>C. pelliculosa<\/jats:italic>\n            , 5 isolates of\n            <jats:italic>C. rugosa<\/jats:italic>\n            , 4 isolates of\n            <jats:italic>C. lipolytica<\/jats:italic>\n            , 3 isolates of\n            <jats:italic>C. dubliniensis<\/jats:italic>\n            , 3 isolates of\n            <jats:italic>C. inconspicua<\/jats:italic>\n            , 2 isolates of\n            <jats:italic>C. sake<\/jats:italic>\n            , and 1 isolate each of\n            <jats:italic>C. lambica<\/jats:italic>\n            ,\n            <jats:italic>C. norvegensis<\/jats:italic>\n            , and\n            <jats:italic>C. zeylanoides<\/jats:italic>\n            . MIC determinations were made by the National Committee for Clinical Laboratory Standards reference broth microdilution method and Etest (amphotericin B). Resistance to both amphotericin B and fluconazole was observed in strains of\n            <jats:italic>C. krusei<\/jats:italic>\n            ,\n            <jats:italic>C. lusitaniae<\/jats:italic>\n            ,\n            <jats:italic>C. guilliermondii<\/jats:italic>\n            ,\n            <jats:italic>C. inconspicua<\/jats:italic>\n            , and\n            <jats:italic>C. sake<\/jats:italic>\n            . Resistance to amphotericin B, but not to fluconazole, was also observed among isolates of\n            <jats:italic>C. kefyr<\/jats:italic>\n            and\n            <jats:italic>C. rugosa<\/jats:italic>\n            . Posaconazole and voriconazole were active (MIC, \u22641 \u03bcg\/ml) against 94 to 100% of these isolates. In contrast to the more common species of\n            <jats:italic>Candida<\/jats:italic>\n            causing bloodstream infection, these rare species appear to be less susceptible to the currently licensed systemic antifungal agents, with the exception of voriconazole. Continued surveillance will be necessary to detect the emergence of these species as more prevalent, resistant pathogens. The new triazoles appear to offer acceptable coverage of uncommon\n            <jats:italic>Candida<\/jats:italic>\n            sp. bloodstream infections.\n          <\/jats:p>","DOI":"10.1128\/jcm.41.1.78-83.2003","type":"journal-article","created":{"date-parts":[[2003,1,7]],"date-time":"2003-01-07T18:03:11Z","timestamp":1041962591000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":136,"title":["In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against\n            <i>Candida<\/i>\n            Species Infrequently Isolated from Blood"],"prefix":"10.1128","volume":"41","author":[{"given":"M. A.","family":"Pfaller","sequence":"first","affiliation":[{"name":"Departments of Pathology"},{"name":"Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Diekema","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Medicine, University of Iowa College of Medicine and College of Public Health, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Messer","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boyken","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Hollis","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. N.","family":"Jones","sequence":"additional","affiliation":[{"name":"The Jones Group\/JMI Laboratories, North Liberty, Iowa"},{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"1122","volume":"24","year":"1996","unstructured":"Abi-Said, D., E. Anaisse, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1996. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis.24:1122-1128.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.19.3.412-416.1984"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.2.295"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.8.1948"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3457-3459.2000"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.3.792-795.1998"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.4.1381-1386.2002"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-1-67"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.1.77"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/520192"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.1.198-202.1998"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010954803886"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.499"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199305000-00002"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.5.1006"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.462"},{"key":"e_1_3_2_18_2","first-page":"1","volume":"46","year":"2000","unstructured":"Jones, R. N. 2000. Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility. J. Antimicrob. Chemother.46(Suppl. T2):1-8.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/313450"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.8.1689-1692.1991"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.11.3018"},{"key":"e_1_3_2_22_2","unstructured":"McGinnis M. R. and M. G. Rinaldi. 1991. Antifungal drugs: mechanisms of action drug resistance susceptibility testing and assays of activity in biological fluids p. 198-257. In V. Lorian (ed.) Antibiotics in laboratory medicine. Williams & Wilkins Baltimore Md."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.20.5.1006-1007.1984"},{"key":"e_1_3_2_24_2","unstructured":"National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(95)00010-0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.7.1664-1665.1990"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.727-731.2000"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.2.123"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.857-869.2001"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.1.339-342.2001"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(94)90106-6"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00120-5"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(97)00178-8"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00160-6"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.9.3254-3259.2001"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.10.3551-3557.2002"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1723-1727.2002"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.11.3533-3539.1999"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/27.5.1138"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/313749"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.2266-2269.2002"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19237"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.40"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.24.5.884-885.1986"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850715)56:2<318::AID-CNCR2820560219>3.0.CO;2-4"},{"key":"e_1_3_2_47_2","first-page":"15","volume":"8","year":"1997","unstructured":"Sullivan, D., and D. Coleman. 1997. Candida dubliniensis: an emerging opportunistic pathogen. Curr. Top. Med. Mycol.8:15-25.","journal-title":"Curr. Top. Med. Mycol."},{"key":"e_1_3_2_48_2","first-page":"361","volume":"1","year":"1999","unstructured":"Verweij, P. E., R. E. de Pauw, and J. F. Meis. 1999. Voriconazole. Curr. Opin. Anti-Infect. Investig. Drugs1:361-372.","journal-title":"Investig. Drugs"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2520"},{"key":"e_1_3_2_50_2","unstructured":"Warren N. G. and K. C. Hazen. 1999. Candida Cryptococcus and other yeasts of medical importance p. 1184-1199. In P. R. Murray E. J. Baron M. A. Pfaller F. C. Tenover and R. H. Yolken (ed.) Manual of clinical microbiology 7th ed. ASM Press Washington D.C."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.2.382"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1086\/340263"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110313251803"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199210000-00014"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.1.78-83.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.1.78-83.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:10:36Z","timestamp":1646446236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.41.1.78-83.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1128\/JCM.41.1.78-83.2003"],"URL":"https:\/\/doi.org\/10.1128\/jcm.41.1.78-83.2003","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"2002-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-10-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}